臓器保存市場の評価：ソリューション・技術・臓器タイプ・エンドユーザー・地域別の機会および予測 (2017～2031年)

世界の臓器保存の市場規模は、2023年の2億8,186万米ドルから、2024年から2031年の予測期間中は6.65%のCAGRで推移し、2031年には4億7,176万米ドルの規模に成長すると予測されています。

臓器保存市場は、世界の臓器移植件数の増加や、臓器保存期間の延長と臓器の高い生存率を維持するための技術の進歩といった原動力の影響を受けて、飛躍的に成長すると予測されています。さらに、投資家による支持と医療支出の増加も市場成長の推進因子となっています。臓器移植の必要性につながる臓器不全症例の増加も臓器保存市場の需要をさらに増大させています。臓器移植手術の増加と臓器に関する研究の急増は、臓器保存ソリューションの需要を大幅に高めています。近年、規制が重視されるようになり、いくつかの関連製品についてさまざまな規制当局の承認が下りたことで、主要企業の市場地位が強化されています。政府の支援や、臓器移植を促進するためのさまざまな非営利団体による取り組みも市場需要をさらに高めています。一方で、臓器移植に伴う高額な費用や合併症が市場成長にとって大きな課題です。また、提供される臓器と実施される臓器移植の間に空白期間があることも市場拡大の障壁となっています。

臓器移植件数の増加

臓器移植件数の増加が、臓器保存製品に対する需要を牽引しています。切り離された臓器は急速に劣化する傾向があるため、臓器保存ソリューションは移植前の臓器を保護する上で大きな役割を果たしています。臓器移植が増加している理由としては、臨床上の進歩、可処分所得の高さ、臓器提供や移植に関する意識の広まりなどが挙げられます。臓器調達・移植ネットワーク(Organ Procurement &Transplantation Network) が発表したデータによると、2023年、死亡臓器提供者数は16,000人と前例のない高水準に達し、13年連続で記録的な提供を達成しました。さらに、この年は臓器移植が目覚ましく増加し、臓器不全を克服するための救命処置が46,000件以上行われました。特に、肝臓移植は初めて10,000件を超え、肺移植は3,000件を超えました。さらに、腎臓移植と心臓移植も年間新記録を樹立し、臓器移植の目覚ましい進歩を浮き彫りにしました。

臓器保存法の進歩

臓器保存法は、臓器移植の結果を最適化するために、長年にわたって徐々に進歩してきました。その後の技術革新には、Collins、Euro-Collins、University of Wisconsin(UW) のソリューションのような洗練された製剤が含まれ、保存期間を延長し、臓器の生存率を高めました。現在、参入事業者は、特に生理学的条件を模倣したダイナミックな環境を提供する機械灌流システムなど、活性化した戦略を持つ製品の開発に注力しています。これらのシステムは、臓器の修復と長期保存の両方の機会を提供し、プロセスの失敗の可能性を減少させます。生体外灌流は、このような機械灌流の拡張の一つであり、さらなる修復メカニズムや再プログラミングプロセスを通じて臓器の回復をさらに高めることを目的としています。

当レポートでは、世界の臓器保存の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の臓器保存市場の展望

• 市場規模・予測
• ソリューション別
  • University of Wisconsin (UW)
  • Custodial HTK
  • Perfadex
  • その他
• 技術別
  • 静的冷蔵保管
  • 低温機械灌流
  • 常温機械灌流
• 臓器タイプ別
  • 腎臓
  • 肝臓
  • 肺
  • 心臓
  • 膵臓
  • その他
• エンドユーザー別
  • 臓器移植センター
  • 病院
  • 専門クリニック
• 地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ
• 企業別の市場シェア

第5章 世界の臓器保存市場の展望：地域別

• 北米
• 欧州
• 南米
• アジア太平洋
• 中東・アフリカ

第6章 市場マッピング

• ソリューション別
• 技術別
• 臓器タイプ別
• エンドユーザー別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進要因
• 成長阻害要因 (課題・抑制要因)

第9章 規制の枠組みとイノベーション

• 臨床試験
• 特許の情勢
• 規制当局の承認
• イノベーション/新興技術

第10章 主要企業の情勢

• 市場リーダー上位5社の競合マトリックス
• 市場リーダー上位5社の市場収益分析
• M&A・ジョイントベンチャー (該当する場合)
• SWOT分析(主要企業)

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• XVIVO Perfusion AB
• TransMedics, Inc.
• Preservation Solutions, Inc.
• Paragonix Technologies, Inc.
• Dr. Franz Kohler Chemie GmbH
• Waters Medical Systems LLC
• OrganOx Limited
• st Century Medicine Inc.
• Bridge to Life Ltd.
• Essential Pharmaceuticals LLC

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1.Global Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 2.Global Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 3.Global Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 4.Global Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 5.Global Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 6.Global Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 7.Global Organ Preservation Market Share (%), By Region, 2017-2031F
• Figure 8.North America Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 9.North America Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 10.North America Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 11.North America Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 12.North America Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 13.North America Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 14.North America Organ Preservation Market Share (%), By Country, 2017-2031F
• Figure 15.United States Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 16.United States Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 17.United States Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 18.United States Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 19.United States Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 20.United States Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 21.Canada Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 22.Canada Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 23.Canada Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 24.Canada Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 25.Canada Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 26.Canada Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 27.Mexico Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 28.Mexico Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 29.Mexico Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 30.Mexico Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 31.Mexico Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 32.Mexico Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 33.Europe Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 34.Europe Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 35.Europe Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 36.Europe Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 37.Europe Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 38.Europe Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 39.Europe Organ Preservation Market Share (%), By Country, 2017-2031F
• Figure 40.Germany Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 41.Germany Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 42.Germany Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 43.Germany Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 44.Germany Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 45.Germany Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 46.France Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 47.France Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 48.France Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 49.France Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 50.France Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 51.France Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 52.Italy Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 53.Italy Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 54.Italy Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 55.Italy Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 56.Italy Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 57.Italy Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 58.United Kingdom Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 59.United Kingdom Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 60.United Kingdom Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 61.United Kingdom Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 62.United Kingdom Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 63.United Kingdom Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 64.Russia Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 65.Russia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 66.Russia Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 67.Russia Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 68.Russia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 69.Russia Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 70.Netherlands Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 71.Netherlands Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 72.Netherlands Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 73.Netherlands Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 74.Netherlands Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 75.Netherlands Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 76.Spain Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 77.Spain Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 78.Spain Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 79.Spain Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 80.Spain Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 81.Spain Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 82.Turkey Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 83.Turkey Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 84.Turkey Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 85.Turkey Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 86.Turkey Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 87.Turkey Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 88.Poland Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 89.Poland Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 90.Poland Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 91.Poland Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 92.Poland Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 93.Poland Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 94.South America Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 95.South America Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 96.South America Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 97.South America Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 98.South America Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 99.South America Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 100.South America Organ Preservation Market Share (%), By Country, 2017-2031F
• Figure 101.Brazil Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 102.Brazil Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 103.Brazil Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 104.Brazil Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 105.Brazil Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 106.Brazil Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 107.Argentina Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 108.Argentina Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 109.Argentina Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 110.Argentina Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 111.Argentina Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 112.Argentina Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 113.Asia-Pacific Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 114.Asia-Pacific Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 115.Asia-Pacific Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 116.Asia-Pacific Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 117.Asia-Pacific Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 118.Asia-Pacific Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 119.Asia-Pacific Organ Preservation Market Share (%), By Country, 2017-2031F
• Figure 120.India Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 121.India Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 122.India Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 123.India Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 124.India Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 125.India Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 126.China Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 127.China Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 128.China Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 129.China Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 130.China Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 131.China Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 132.Japan Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 133.Japan Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 134.Japan Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 135.Japan Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 136.Japan Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 137.Japan Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 138.Australia Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 139.Australia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 140.Australia Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 141.Australia Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 142.Australia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 143.Australia Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 144.Vietnam Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 145.Vietnam Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 146.Vietnam Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 147.Vietnam Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 148.Vietnam Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 149.Vietnam Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 150.South Korea Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 151.South Korea Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 152.South Korea Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 153.South Korea Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 154.South Korea Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 155.South Korea Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 156.Indonesia Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 157.Indonesia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 158.Indonesia Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 159.Indonesia Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 160.Indonesia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 161.Indonesia Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 162.Philippines Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 163.Philippines Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 164.Philippines Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 165.Philippines Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 166.Philippines Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 167.Philippines Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 168.Middle East & Africa Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 169.Middle East & Africa Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 170.Middle East & Africa Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 171.Middle East & Africa Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 172.Middle East & Africa Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 173.Middle East & Africa Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 174.Middle East & Africa Organ Preservation Market Share (%), By Country, 2017-2031F
• Figure 175.Saudi Arabia Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 176.Saudi Arabia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 177.Saudi Arabia Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 178.Saudi Arabia Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 179.Saudi Arabia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 180.Saudi Arabia Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 181.UAE Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 182.UAE Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 183.UAE Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 184.UAE Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 185.UAE Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 186.UAE Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 187.South Africa Organ Preservation Market, By Value, In USD Million, 2017-2031F
• Figure 188.South Africa Organ Preservation Market, By Volume, In Million Units, 2017-2031F
• Figure 189.South Africa Organ Preservation Market Share (%), By Solution, 2017-2031F
• Figure 190.South Africa Organ Preservation Market Share (%), By Technique, 2017-2031F
• Figure 191.South Africa Organ Preservation Market Share (%), By Organ Type, 2017-2031F
• Figure 192.South Africa Organ Preservation Market Share (%), By End-user, 2017-2031F
• Figure 193.By Solution Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 194.By Technique Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 195.By Organ Type Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 196.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Global organ preservation market is projected to witness a CAGR of 6.65% during the forecast period 2024-2031, growing from USD 281.86 million in 2023 to USD 471.76 million in 2031. The organ preservation market is anticipated to thrive exponentially under the influence of driving forces like the growing number of organ transplants being performed worldwide, and technological advancements to enhance the preservation time and maintain the high viability of organs. Additionally, rising investors' traction and healthcare spending also catalyze the market growth. Rising cases of organ failure leading to the requisite of organ transplantation further increase the demand in the organ preservation market. The increasing number of organ transplant procedures and the surging research being performed on organs have significantly increased the demand for organ preservation solutions. Increasing regulatory emphasis and various regulatory approvals for several relevant products in recent years have strengthened the market position of key players. Government support and initiatives taken by various non-profit organizations to facilitate organ transplants further enhance the demand in the market. However, the high cost associated with organ transplants and the complications associated with it are major challenges for market growth. The lacuna between the organs donated and organ transplants performed creates another barrier to market expansion.

Increasing Number of Organ Transplants

The increasing number of organ transplants is driving the demand for organ preservation products. Organ preservation solutions play a major role in safeguarding organs before transplantation, as isolated organs tend to deteriorate quickly. The reasons for increasing organ transplants include clinical advancements, high disposable income, and widespread awareness about organ donation and transplants. As per the data published by the Organ Procurement & Transplantation Network, in 2023, the number of deceased organ donors reached an unprecedented high of 16,000, marking 13 consecutive years of record-breaking donations. Moreover, the year witnessed an impressive increase in organ transplants, with over 46,000 life-saving procedures performed to overcome organ failures. Notably, liver transplants crossed the 10,000 mark for the first time, while lung transplants exceeded 3,000. Additionally, kidney and heart transplants also set new annual records, underscoring the remarkable progress in organ transplantation. Similarly, around 1589 kidney transplants, 761 liver, and 250 heart transplants were reported with India in the deceased category throughout the year 2022.

Advancements in Organ Preservation Methods

Organ preservation methods have progressively advanced throughout history, for the sake of optimizing organ transplantation outcomes. Subsequent innovations included refined formulations like the Collins, Euro-Collins, and University of Wisconsin (UW) solutions, which extended storage durations and enhanced organ viability. Presently, market players are focusing on developing products with revitalized strategies, particularly machine perfusion systems that offer a dynamic environment mimicking physiologic conditions. These systems provide opportunities for both organ repair and prolonged storage periods, reducing the chances of process failure. Ex vivo perfusion is one such extension of machine perfusion which aims to further enhance organ recovery through additional repair mechanisms and reprogramming processes.

In August 2023, TransMedics Group, Inc. announced the acquisition of assets and intellectual property from Bridge to Life Ltd., specifically the Ex-Vivo Organ Support System (EVOSS) and the LifeCradle Heart Preservation Transport System. LifeCradle is a cold perfusion technology used in heart transplantation, whereas EVOSS is a warm perfusion method used in lung and heart transplantation. As the company concentrates on expanding its product portfolio and applications in organ transplantation, TransMedics seeks to enhance these technologies.

Dominance of Static Cold Storage Technique

Static cold storage is preferred for organ preservation because it is a simple, cost-effective, and widely adopted method. It involves flushing the procured organ with preservation solution at a very low temperature and then immersing it in the same solution at the same temperature until transplantation. This technique significantly slows down cellular metabolism and maintains organ integrity, while minimizing the need for specialized equipment and reducing costs associated with alternative methods like machine perfusion. The cost-effectiveness of the static cold storage method is the major factor strengthening the lead of this technique. The hypothermic machine perfusion system segment is anticipated to grow at a relatively faster pace with the highest CAGR as market players are constantly working on it. For instance, in May 2023, Bridge to Life, Ltd. reported meeting promising standards from an interim analysis, prompting an early enrollment conclusion for its multicenter, randomized, controlled Bridge to HOPE Liver Clinical Trial (NCT05045794). This trial evaluates the clinical safety and effectiveness of the static cold storage (SCS) method, the conventional ex-vivo organ preservation technique, against a combination of SCS and hypothermic oxygenated perfusion (HOPE) using the VitaSmart Liver Machine Perfusion System. The trial is being conducted under a U.S. Food and Drug Administration (FDA)-approved investigational device exemption (IDE).

Kidney is the Most Commonly Preserved Organ

Kidneys are the most transplanted organ due to several factors. Kidney transplantation has a higher success rate, offering patients a better quality of life and increased longevity compared to remaining on dialysis. Kidney transplantation does not require removing the recipient's kidneys unless they are severely damaged or causing problems like high blood pressure or infection, making it less invasive than other types of organ transplantation. Additionally, compared to other vital organs like the heart, liver, and lungs, there are relatively more suitable kidney donors available, contributing to the frequency of kidney transplantation. Due to the high number of kidney transplants, the demand for preservation products for kidneys is anticipated to be higher. For instance, in 2023, kidney transplants in the United States reached an all-time high, with 27,329 surgeries performed as reported by the Organ Procurement and Transplantation Network (OPTN). Out of these transplantations, more than 6,900 involved living donors, with kidney transplants comprising over 90% of them. Additionally, the year saw an increase in the number of organ transplants, including kidney transplants, for Black and Hispanic individuals.

North America to be the Dominating Region

North America region is expected to dominate the market with a high-value share throughout the assessment period owing to the growing public commitment to organ donation and collaboration among donor hospitals, organ procurement organizations, and transplant hospitals, as well as advancements in organ preservation techniques and scientific breakthroughs. The United States being a medically advanced nation, has crossed the milestone of 1 million organ transplants in the year 2022. The technological advancements in the region to facilitate organ transplants have further boosted the market expansion in the region. Manufacturers also keep up their position by innovating new products.

For instance, in November 2023, Paragonix Technologies unveiled an extensive network of organ procurement, preservation, and transportation services. Seven specialized hubs have been strategically positioned across the United States to streamline coordination and support. These centers operate round the clock, featuring over 50 experienced professionals like surgeons and preservation experts, demonstrating Paragonix's commitment to revolutionizing organ transplantation.

Future Market Scenario (2024 - 2031F)

Machine perfusion is a new technique to keep organs healthy for transplantation. It works by using a special liquid that flows through the organ to keep it alive. This allows the organ to be stored for longer periods and repaired if it is damaged. Researchers are working to develop even better machine perfusion techniques and solutions to make organs even healthier before transplantation. This could lead to more successful transplants and save more lives. For instance, in March 2023, The FDA granted XT-ViVo and TimeSeal a special designation called "Breakthrough Device Designation" because they can preserve and store kidneys for up to 120 hours. These products could be used to preserve other organs and tissues. Current methods preserve organs for only 4-16 hours, leading to waste, discarding, and countless organs not being recovered. In February 2023, LivaNova PLC unveiled the Essenz Perfusion System in Europe for cardiopulmonary bypass surgical interventions. This cutting-edge device combines a sophisticated heart-lung machine with a revolutionary patient monitor, delivering real-time critical care insights during CPB procedures.

Key Players Landscape and Outlook

XVIVO Perfusion AB, TransMedics, Inc., Preservation Solutions, Inc., Paragonix Technologies, Inc., Dr. Franz Kohler Chemie GmbH, and Waters Medical Systems LLC are some of the renowned players in the organ preservation market. These companies focus on developing and supplying organ preservation solutions, such as University of Wisconsin (UW) Solution, Custodial HTK, Perfadex, and others, while employing different preservation techniques like static cold storage, hypothermic machine perfusion, and normothermic machine perfusion. Regulatory advancements and collaboration lead the way for market expansion. The market is mainly dominated by privately held companies.

In February 2024, Bridge to Life Ltd announced that it had received ISO 13485:2016 certification. This achievement highlights the company's dedication to quality and safety in its products, including Belzer UW, EasiSlush, and VitaSmart1 Machine Perfusion System (Europe). The certification is a strategic move in preparation for the launch of the VitaSmart1 Machine Perfusion System in the US, pending FDA approval. Bridge to Life consistently strives to meet and surpass industry standards.

In February 2024, Atrium Health's Transplant Division, Carolinas Medical Center, joined forces with LifeShare Carolinas and BMI OrganBank to introduce pioneering Organ Banking technology. This advanced system will expand organ preservation and reconditioning possibilities. Atrium Health is among the top five Integrated Delivery Networks in the United States.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Organ Preservation Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2.By Solution
  • 4.2.1.University of Wisconsin Solution (UW Solution)
  • 4.2.2.Custodial HTK
  • 4.2.3.Perfadex
  • 4.2.4.Other Solutions
• 4.3.By Technique
  • 4.3.1.Static Cold Storage
  • 4.3.2.Hypothermia Machine Perfusion
  • 4.3.3.Normothermic Machine Perfusion
• 4.4.By Organ Type
  • 4.4.1.Kidney
  • 4.4.2.Liver
  • 4.4.3.Lung
  • 4.4.4.Heart
  • 4.4.5.Pancreas
  • 4.4.6.Others
• 4.5.By End-user
  • 4.5.1.Organ Transplant Centers
  • 4.5.2.Hospitals
  • 4.5.3.Specialty Clinics
• 4.6.By Region
  • 4.6.1.North America
  • 4.6.2.Europe
  • 4.6.3.Asia-Pacific
  • 4.6.4.South America
  • 4.6.5.Middle East and Africa
• 4.7.By Company Market Share (%), 2023

5.Global Organ Preservation Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
    • 5.1.1.2.By Volume
  • 5.1.2.By Solution
    • 5.1.2.1.University of Wisconsin Solution (UW Solution)
    • 5.1.2.2.Custodial HTK
    • 5.1.2.3.Perfadex
    • 5.1.2.4.Other Solutions
  • 5.1.3.By Technique
    • 5.1.3.1.Static Cold Storage
    • 5.1.3.2.Hypothermia Machine Perfusion
    • 5.1.3.3.Normothermic Machine Perfusion
  • 5.1.4.By Organ Type
    • 5.1.4.1.Kidney
    • 5.1.4.2.Liver
    • 5.1.4.3.Lung
    • 5.1.4.4.Heart
    • 5.1.4.5.Pancreas
    • 5.1.4.6.Others
  • 5.1.5.By End-user
    • 5.1.5.1.Organ Transplant Centers
    • 5.1.5.2.Hospitals
    • 5.1.5.3.Specialty Clinics
  • 5.1.6.United States*
    • 5.1.6.1.Market Size & Forecast
    • 5.1.6.1.1.By Value
    • 5.1.6.1.2.By Volume
    • 5.1.6.2.By Solution
    • 5.1.6.2.1.University of Wisconsin Solution (UW Solution)
    • 5.1.6.2.2.Custodial HTK
    • 5.1.6.2.3.Perfadex
    • 5.1.6.2.4.Other Solutions
    • 5.1.6.3.By Technique
    • 5.1.6.3.1.Static Cold Storage
    • 5.1.6.3.2.Hypothermia Machine Perfusion
    • 5.1.6.3.3.Normothermic Machine Perfusion
    • 5.1.6.4.By Organ Type
    • 5.1.6.4.1.Kidney
    • 5.1.6.4.2.Liver
    • 5.1.6.4.3.Lung
    • 5.1.6.4.4.Heart
    • 5.1.6.4.5.Pancreas
    • 5.1.6.4.6.Others
    • 5.1.6.5.By End-user
    • 5.1.6.5.1.Organ Transplant Centers
    • 5.1.6.5.2.Hospitals
    • 5.1.6.5.3.Specialty Clinics
  • 5.1.7.Canada
  • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East & Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Solution
• 6.2.By Technique
• 6.3.By Organ Type
• 6.4.By End-user
• 6.5.By Region

7.Macro Environment and Industry Structure

• 7.1.Demand Supply Analysis
• 7.2.Import Export Analysis
• 7.3.Value Chain Analysis
• 7.4.PESTEL Analysis
  • 7.4.1.Political Factors
  • 7.4.2.Economic System
  • 7.4.3.Social Implications
  • 7.4.4.Technological Advancements
  • 7.4.5.Environmental Impacts
  • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5.Porter's Five Forces Analysis
  • 7.5.1.Supplier Power
  • 7.5.2.Buyer Power
  • 7.5.3.Substitution Threat
  • 7.5.4.Threat from New Entrant
  • 7.5.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

• 9.1.Clinical Trials
• 9.2.Patent Landscape
• 9.3.Regulatory Approvals
• 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

• 13.1.XVIVO Perfusion AB
  • 13.1.1.Company Details
  • 13.1.2.Key Management Personnel
  • 13.1.3.Products & Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Key Market Focus & Geographical Presence
  • 13.1.6.Recent Developments
• 13.2.TransMedics, Inc.
• 13.3.Preservation Solutions, Inc.
• 13.4.Paragonix Technologies, Inc.
• 13.5.Dr. Franz Kohler Chemie GmbH
• 13.6.Waters Medical Systems LLC
• 13.7.OrganOx Limited
• 13.8.21st Century Medicine Inc.
• 13.9.Bridge to Life Ltd.
• 13.10.Essential Pharmaceuticals LLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer